Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol
Hold the needle in place for a few seconds after injecting the medication to ensure it has been delivered completely
Whole-mount embryo alkaline phosphatase staining and ISH For alkaline phosphatase staining, E8.5 embryos were fixed in 4% paraformaldehyde for 15 min at room temperature or overnight at 4 C and then washed twice with TBST
Many people know GLP-1 medications for their role in weight management, but research now shows that these therapies may also support blood sugar control, cardiovascular health, inflammation reduction, longevity, cognition, and metabolic health
